Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Salarius Pharmaceuticals (SLRX) Earnings Date, Estimates & Call Transcripts

Salarius Pharmaceuticals logo

Salarius Pharmaceuticals Earnings Summary

Salarius Pharmaceuticals released Q3 2025 earnings on November 14, 2025, reporting an EPS of -$1.81, which topped analysts' consensus estimates of -$33.60 by $31.79. Salarius Pharmaceuticals currently has a trailing EPS of -$33.89

Latest Q3
Earnings Date
Nov. 14Estimated
Consensus EPS
(Nov. 14)
-$33.60
Actual EPS
(Nov. 14)
-$1.81 Beat By $31.79

Q3 2025 Earnings Resources

Get Salarius Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Salarius Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

SLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Salarius Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/14/2025Q3 2025-$33.60-$1.81+$31.79-$1.81--
8/12/2025Q2 2025-$33.00-$0.45+$32.55-$0.45--
5/14/2025Q1 2025-$36.00-$15.45+$20.55-$1.03--
3/21/2025Q4 2024-$34.65-$9.90+$24.75-$0.66--
8/9/2024--$804.00-$35.55+$768.45-$2.37--
5/13/2024Q1 2024-$804.00-$49.20+$754.80-$0.41--

Data powered by Fiscal.ai.


This page (NASDAQ:SLRX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners